What Commission Implementing Regulation (EU) 2021/1379 of 19 August 2021 concerning the non-renewal of approval of the active substance famoxadone, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance) requires
The European Commission has decided not to renew the approval of the active substance famoxadone under Regulation (EC) No 1107/2009 concerning the placing of plant protection products on the market…
This is a preview. The full record adds the complete summary, 8 workflow steps, 10 schema fields and 6 primary citations. Start a free trial or see pricing.
Pillar: Legal & IP Sovereignty · Authority: THE EUROPEAN COMMISSION · Version: 1.0.0 · Last updated:
Primary source: https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32021R1379
SHA-256 integrity: fb5a11187036a216a686991c30a529de123b97cc87655353c646b57c2dc16a5d
Primary Citations — 6 traced to source
- Article 1: The approval of the active substance famoxadone is not renewed.
- Article 2: In Part A of the Annex to Implementing Regulation (EU) No 540/2011, row 35, on famoxadone, is deleted.
+ 4 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/eu-celex-32021r1379.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/eu-celex-32021r1379.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/eu-celex-32021r1379
- Back to registry: Browse all 10,084 compliance nodes